Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 27, 1998

View Archived Issues

Dainippon will initiate European development of antipsychotic drug candidate

Dainippon's aldose reductase inhibitor in phase II in Japan; European development now planned

Preparation and pharmaceutical formulations of nimesulide choline salt claimed by Dompe

Korean research institute develops new NMDA receptor antagonists

Agents for schizophrenia from Yoshitomi typified by Y-36074

RPR presents clinical findings with gpIIb/IIIa antagonist; product dropped due to dosing problems

Apotex conducting early studies on oral chelating agents

NeoTect effective in detecting breast cancer in early clinical study

Yamanouchi discloses 5-HT2C receptor agonists with high potency and selectivity

GeneMedicine, Megabios merger will create industry leader in gene-based therapeutics

Shiseido claims pyrrolidines for gastric and peptic ulcers

Vasogen files for protection of patient-specific treatment of GvHD

New serotonergic agents in development at ADIR for CNS disorders

ThromboSol prolongs cryopreservation of rhTPO-stimulated platelets in in vitro study

Pharmacokinetic and therapeutic equivalence of Zelapar and Eldepryl

AxyS reaches research milestones in collaboration with Warner-Lambert

No risk of liver toxicity with entacapone, Orion says

Clinical, preclinical efficacy of Neovastat featured at recent congress

Temodal recommended for approval in E.U.

Clinical testing of nonantibiotic anti-H. pylori agent will begin; development partner sought

Clinical trials of FS069 begin in Japan

New antiasthmatic agent launched in Italy by Zeneca, Chiesi and Recordati

Idec commences clinical trials with PRIMATIZED anti-B7 antibody in psoriasis

Advisory committee decides against recommending approval for new anticoagulant

New synthetic anti-HIV compound resembling NNRTIs in development at Nippon Suisan

Hughes Institute develops potent and selective d4T analogue as anti-HIV candidate

Design and synthesis of new beta-lactams as potent and selective HCMV protease inhibitors

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...